Tirzepatide Pen (Revion+)

Description

Tirzepatide is a synthetic research compound studied for its dual activity at GLP-1 and GIP receptors. These pre-filled research pens are supplied ready-to-use to support controlled dosing in laboratory and research environments.

•  (Type 2 Diabetes): Approved for adults and children aged 10 and older to improve blood sugar control.
•  (Weight Management):Approved for chronic weight management in adults with obesity (BMI≥30) or overweight (BMI≥27) with at least one weight-related condition.
• Obstructive Sleep Apnea (OSA): Approved (as Zepbound) to treat moderate-to-severe OSA in adults with obesity